Treatment & Guidelines
93% of patients who underwent TAVI said improved QoL was their primary treatment goal. Patients favoured the ability to enjoy their regular activities and spend time with loved ones over goals relating to heart failure symptomatology: *
Data from the PARTNER 3, II S3i, 1A and 1B Trials show that patients receiving TAVI enjoyed a better health status post-procedure compared to control group (sAVR or standard treatment), as measured using the Kansas City Cardiomyopathy Questionnaire (KCCQ).
In low-risk ssAS patients, SAPIEN 3 TAVI provided substantially improved health status at 1 month (16.0 points; 95% CI 14.2 to 17.8; p<0.001), 6 months (2.6 points; 95% CI 1.0 to 4.3; p=0.002) and 1 year (1.8 points; 95% CI 0.1 to 3.5; p=0.033) compared to sAVR:3
KCCQ overall summary (OS) score
Adapted from Baron SJ et al. 2019.
What could a TAVI referral mean for your ssAS patients?
Content relating to Tavi.today is intented for healthcare professionals. Click OK to confirm you are a healthcare professional and proceed.